Clinical Trial Update: Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

View source ↗

Summary

This clinical trial is developing a risk-stratification score to predict recurrent venous thromboembolism and treatment-related bleeding in patients with cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-associated Thrombosis

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Cancer-associated Thrombosis | Status: RECRUITING